Ixekizumab for moderate to severe chronic plaque psoriasis

First Page		Document Content
Monoclonal antibodies Pharmacology Psoriasis Centocor Autoimmune diseases Ustekinumab Psoriatic nails Infliximab Etanercept Medicine Immunosuppressants Health		Ixekizumab for moderate to severe chronic plaque psoriasis Add to Reading List Source URL: www.hsc.nihr.ac.uk Download Document from Source Website File Size: 161,78 KB Share Document on Facebook

	www.medscape.com/viewarticle/864011_print www.medscape.com DocID: 1pzpz - View Document
	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE DocID: 1ceTm - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document